Joshua D Amason - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Joshua D Amason

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

... International Conference on Learning Representations|February 16, 2026

Gradient Importance Learning for Incomplete ObservationsQitong Gao, Dong Wang, Joshua D Amason, et al.

Plos One|April 3, 2020

A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncologyTeresa L Burgess, Joshua D Amason, Jeffrey S Rubin, et al.

Plos One|July 6, 2019

Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitorsThomas W Miller, Joshua D Amason, Elsa D Garcin, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

... International Conference on Learning Representations|February 16, 2026

Gradient Importance Learning for Incomplete ObservationsQitong Gao, Dong Wang, Joshua D Amason, et al.

Plos One|April 3, 2020

A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncologyTeresa L Burgess, Joshua D Amason, Jeffrey S Rubin, et al.

Plos One|July 6, 2019

Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitorsThomas W Miller, Joshua D Amason, Elsa D Garcin, et al.

Pageof 1